Determinants of arsenic metabolism: Blood arsenic metabolites, plasma folate, cobalamin, and homocysteine concentrations in maternal-newborn pairs

Environmental Health Perspectives

Volumn 115, Issue 10, 2007, Pages 1503-1509

  Hall, Marni ^a   Gamble, Mary ^a   Slavkovich, Vesna ^a   Liu, Xinhua ^a   Levy, Diane ^a   Cheng, Zhongqi ^b   van Geen, Alexander ^b   Yunus, Mahammad ^c   Rahman, Mahfuzar ^c   Pilsner, J Richard ^a   Graziano, Joseph ^a,d  

^a Columbia University Medical Center ^*  (United States)

^b Department of Earth and Environmental Sciences   (United States)

^c ICDDR B Centre for Health and Population Research   (Bangladesh)

^d NONE   (United States)

Author keywords

Arsenic; B12; Blood arsenic metabolites; DMA; Folate; Homocysteine; Maternal; MMA; Newborn

Indexed keywords

ARSENIC; ARSENIC ACID; ARSENIC DERIVATIVE; ARSENIC TRIOXIDE; CACODYLIC ACID; COBALAMIN; DRINKING WATER; FOLIC ACID; HOMOCYSTEINE;

ADOLESCENT; ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BANGLADESH; BLOOD ANALYSIS; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FETOTOXICITY; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLITE; NEWBORN; PREDICTION; PREGNANT WOMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; UMBILICAL CORD BLOOD; WATER CONTAMINATION; WORLD HEALTH ORGANIZATION;

ADULT; ARSENIC; ARSENIC POISONING; BANGLADESH; BIOLOGICAL MARKERS; COHORT STUDIES; ENVIRONMENTAL EXPOSURE; FEMALE; FETAL BLOOD; FOLIC ACID; HOMOCYSTEINE; HUMANS; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; PREGNANCY; VITAMIN B 12; WATER SUPPLY;

EID: 35448960833     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.9906     Document Type: Article

References (52)

1. Ahmad SA, Sayed MH, Barua S, Khan MH, Faruquee MH, Jalil A, et al. 2001. Arsenic in drinking water and pregnancy outcomes. Environ Health Perspect 109:629-631.
2. Anderson LM, Diwan BA, Fear NT, Roman E. 2000. Critical windows of exposure for children's health: cancer in human epidemiological studies and neoplasms in experimental animal models. Environ Health Perspect 108(suppl 3):573-594.
3. Aposhian HV, Zakharyan RA, Avram MD, Sampayo-Reyes A, Wollenberg ML. 2004. A review of the enzymology of arsenic metabolism and a new potential role of hydrogen peroxide in the detoxification of the trivalent arsenic species. Toxicol Appl Pharmacol 198:327-335.
4. Borzsonyi M, Bereczky A, Rudnai P, Csanady M, Horvath A. 1992. Epidemiological studies on human subjects exposed to arsenic in drinking water in southeast Hungary. Arch Toxicol 66(1):77-78.
5. Buchet JP, Lauwerys R, Roels H. 1981. Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate, or dimethylarsinate in man. Int Arch Occup Environ Health 48(1):71-79.
6. Chen YC, Guo YL, Su HJ, Hsueh YM, Smith TJ, Ryan LM, et al. 2003a. Arsenic methylation and skin cancer risk in southwestern Taiwan. J Occup Environ Med 45(3):241-248.
7. Chen YC, Su HJ, Guo YL, Hsueh YM, Smith TJ, Ryan LM, et al. 2003b. Arsenic methylation and bladder cancer risk in Taiwan. Cancer Causes Control 14(4):303-310.
8. Cheng ZY, Zheng Y, Mortlock R, van Geen A. 2004. Rapid multi-element analysis of groundwater by high-resolution inductively coupled plasma mass spectrometry. Anal Bioanal Chem 379:513-518.
9. Chowdhury AM. 2004. Arsenic crisis in Bangladesh. Sci Am 291(2):86-91.
10. Christenson Rh, Dent Ga, Tuszynski A. 1985. Two radioassays for serum vitamin B12 and folate determination compared in a reference interval study. Clin Chem 31:1358-1360.
11. Concha G, Vogler G, Lezcano D, Nermell B, Vahter M. 1998. Exposure to inorganic arsenic metabolites during early human development. Toxicol Sci 44(2):185-190.
12. Csanaky I, Nemeti B, Gregus Z. 2003. Dose-dependent biotransformation of arsenite in rats - not S-adenosylmethionine depletion impairs arsenic methylation at high dose. Toxicology 183(1-3):77-91.
13. Davis CD, Uthus EO. 2004. DNA methylation, cancer susceptibility, and nutrient interactions. Exp Biol Med (Maywood) 229(10):988-995.
14. DeSesso JM, Jacobson CF, Scialli AR, Farr CH, Holson JF. 1998. An assessment of the developmental toxicity of inorganic arsenic. Reprod Toxicol 12(4):385-433.
15. Gamble MV, Ahsan H, Liu X, Factor-Litvak P, Ilievski V, Slavkovich V, et al. 2005a. Folate and cobalamin deficiencies and hyperhomocysteinemia in Bangladesh. Am J Clin Nutr 81(6):1372-1377.
16. Gamble MV, Liu X, Ahsan H, Pilsner R, Ilievski V, Slavkovich V, et al. 2005b. Folate, homocysteine and arsenic metabolism in arsenic-exposed individuals in Bangladesh. Environ Health Perspect 113:1683-1688.
17. Gamble MV, Liu X, Ahsan H, Pilsner JR, Illievski, V, Slavkovich V, et al. 2006. Folate and arsenic metabolism: a double-blind placebo controlled folic acid supplementation trial in Bangladesh. Am J Clin Nutr 84:1093-1101.
18. George L, Mills JL, Johansson AL, Nordmark A, Olander B, Granath F, et al. 2002. Plasma folate levels and risk of spontaneous abortion. JAMA 288(15):1867-1873.
19. 12. BJOG 109:784-791.
20. Hall M, Chen Y, Ahsan H, Slavkovich V, van Geen A, Parvez F, et al. 2006. Blood arsenic as a biomarker of arsenic exposure: results from a prospective study. Toxicology 225(2-3):225-233.
21. Hopenhayn C, Ferreccio C, Browning SR, Huang B, Peralta C, Gibb H, et al. 2003. Arsenic exposure from drinking water and birth weight. Epidemiology 14(5):593-602.
22. Hopenhayn-Rich C, Browning SR, Hertz-Picciotto I, Ferreccio C, Peralta C, Gibb H. 2000. Chronic arsenic exposure and risk of infant mortality in two areas of Chile. Environ Health Perspect 108:667-673.
23. Hsueh YM, Chiou HY, Huang YL, Wu WL, Huang CC, Yang MH, et al. 1997. Serum beta-carotene level, arsenic methylation capability, and incidence of skin cancer. Cancer Epidemiol Biomarkers Prev 6(8):589-596.
24. Milton AH, Hasan Z, Shahidullah SM, Sharimin S, Jakarya MD, Rahman M, et al. 2004. Association between nutritional status and arsenicosis due to chronic arsenic exposure in Bangladesh. Int J Environ Health Res 14 (2):99-108.
25. 12, and the 5,10-methylenetetrahydrofolate reductase 677C → T variant. Am J Obstet Gynecol 186:499-503.
26. 12, Pantothenic Acid, Biotin, and Choline. Washington, DC:National Academy Press.
27. NRC (National Research Council). 1999. Arsenic in Drinking Water. Washington, DC:National Academy Press.
28. Nixon DE, Mussmann GV, Ecktahdahl SJ, Moyer TP. 1991. Total arsenic in urine: palladium-persulfate vs nickel as a matrix modifier for graphite furnace atomic absorption spectrophotometry. Clin Chem 37:1575-1579.
29. Obeid R, Munz W, Werner S, Herrmann W. 2005. Biochemical indexes of the B vitamins in cord serum are predicted by maternal B vitamin status. Am J Clin Nutr 82:133-139.
30. Pfeiffer CM, Huff DL, Gunter EW. 1999. Rapid and accurate HPLC assay for plasma total homocysteine and cysteine in a clinical laboratory setting. Clin Chem 45(2):290-292.
31. Pi J, Yamauchi H, Kumagai Y, Sun G, Yoshida T, Aikawa H, et al. 2002. Evidence for induction of oxidative stress caused by chronic exposure of Chinese residents to arsenic contained in drinking water. Environ Health Perspect 110:331-336.
32. Picciano MF. 2003. Pregnancy and lactation: physiological adjustments, nutritional requirements and the role of dietary supplements. J Nutr 133 (6):1997S-2002S.
33. Reuter W, Neubauer K, 2003. Speciation of Five Arsenic Compound in Urine by HPLC/ICP-MS. Franklin, MA:PerkinElmerSCIEX, PerkinElmer Life and Analytical Sciences.
34. Rossman TG, Uddin AN, Burns FJ. 2004. Evidence that arsenite acts as a cocarcinogen in skin cancer. Toxicol Appl Pharmacol 198(3):394-404.
35. Slot C. 1965. Plasma creatinine determination. A new and specific Jaffe reaction method. Scand J Clin Lab Invest 17(4):381-387.
36. Soong YK, Tseng R, Liu C, Lin PW. 1991. Lead, cadmium, arsenic, and mercury levels in maternal and fetal cord blood. J Formos Med Assoc 90(1):59-65.
37. Spiegelstein O, Lu X, Le XC, Troen A, Selhub J, Melnyk S, et al. 2003. Effects of dietary folate intake and folate binding protein-1 (Folbp1) on urinary speciation of sodium arsenate in mice. Toxicol Lett 145 (2):167-174.
38. Steegers-Theunissen RPM, Wathen NC, Eskes TKAB, van Raaij-Selten B, Chard T. 1997. Maternal and fetal levels of methionine and homocysteine in early human pregnancy. Br J Obstet Gynaecol 104:20-24.
39. Tamura T, Picciano MF. 2006. Folate and human reproduction. Am J Clin Nutr 83:993-1016.
40. Thomas DJ, Waters SB, Styblo M. 2004. Elucidating the pathway for arsenic methylation. Toxicol Appl Pharmacol 198(3):319-326.
41. Tseng CH, Huang YK, Huang YL, Chung CJ, Yang MH, Chen CJ, et al. 2005. Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. Toxicol Appl Pharmacol 206(3):299-308.
42. Vahter M. 2000. Genetic polymorphism in the biotransformation of inorganic arsenic and its role in toxicity. Toxicol Lett 112-113:209-217.
43. Vahter M, Concha G. 2001. Role of metabolism in arsenic toxicity. Pharmacol Toxicol 89(1):1-5.
44. Vahter M, Marafante E. 1987. Efects of low dietary intake of methionine, choline or proteins on the biotransformation of arsenite in the rabbit. Toxicol Lett 37 (1):41-46.
45. van Geen A, Cheng Z, Seddique AA, Hoque MA, Gelman A, Graziano JH, et al. 2005. Reliability of a commercial kit to test groundwater for arenic in Bangladesh. Environ Sci Technol 39:299-303.
46. Waalkes MP, Liu J, Ward JM, Bhalchandra AD. 2004. Animal models for arsenic carcinogenesis: inorganic arsenic is a transplacental carcinogen in mice. Toxicol Appl Pharmacol 198:377-384.
47. Waalkes MP, Liu J, Ward JM, Diwan BA. 2006. Enhanced bladder and liver carcinogenesis in male CD1 mice exposed to transplacental inorganic arsenic and postnatal diethyl-stilbestrol or tamoxifen. Toxicol Appl Pharmacol 215(3):295-305.
48. Wasserman G, Liu X, Parvez F, Ahsan H, Factor-Litvak P, Kline J, et al. 2007. Water arsenic exposure and intellectual function in 6-year-old children in Araihazar, Bangladesh. Environ Health Perspect 115:285-289.
49. Wasserman GA, Liu X, Parvez F, Ahsan H, Factor-Litvak P, van Geen A, et al. 2004. Water arsenic exposure and children's intellectual function in Araihazar, Bangladesh. Environ Health Perspect 112:1329-1333.
50. Yang CY, Chang CC, Tsai SS, Chuang HY, Ho CK, Wu TN. 2003. Arsenic in drinking water and adverse pregnancy outcome in an arseniasis-endemic area in northeastern Taiwan. Environ Res 91(1):29-34.
51. Yu RC, Hsu KH, Chen CJ, Froines JR. 2000. Arsenic methylation capacity and skin cancer. Cancer Epidemiol Biomarkers Prev 9(11):1259-1262.
52. Zheng, Y, Stute M, van Geen A, Gavrieli I, Dhar R, Simpson HJ, et al. 2004. Redox control of arsenic mobilization in Bangladesh groundwater. Appl Geochem 19:201-214.